{
    "eid": "2-s2.0-84992677748",
    "title": "TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma",
    "cover-date": "2016-08-01",
    "subject-areas": [
        {
            "$": "Pathology and Forensic Medicine",
            "@code": "2734"
        }
    ],
    "keywords": [
        "automated image analysis",
        "differential diagnosis",
        "immunohistochemistry",
        "papillary thyroid carcinoma",
        "thyroid",
        "TROP-2"
    ],
    "authors": [
        "Andrey Bychkov"
    ],
    "citedby-count": 33,
    "ref-count": 45,
    "ref-list": [
        "Trop2 and its overexpression in cancers: Regulation and clinical/therapeutic implications",
        "Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: Potential implications as a cancer therapeutic target",
        "TROP-2 expression in papillary thyroid cancer: A preliminary cyto-histological study",
        "Application of immunohistochemistry in thyroid pathology",
        "TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility",
        "Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer",
        "Digital imaging in pathology: Whole-slide imaging and beyond",
        "Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue",
        "BRAF V600E mutation and papillary thyroid cancer - In reply",
        "Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.",
        null,
        "Application of immunohistochemistry to thyroid neoplasms",
        "CD117: A novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies",
        "Pitfalls in thyroid tumour pathology",
        "Expression of YY1 in Differentiated Thyroid Cancer",
        "Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry",
        "Clusterin transcript variants expression in thyroid tumor: A potential marker of malignancy?",
        "A novel stem cell associated marker identified by monoclonal antibody HESC5:3 differentiates between neoplastic lesions in follicular thyroid neoplasms",
        "Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas",
        "Human TROP-2 is a tumor-associated calcium signal transducer",
        "Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: Implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody",
        "Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors",
        "TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors",
        "Trop-2 is a determinant of breast cancer survival",
        "TROP2: A novel prognostic marker in squamous cell carcinoma of the oral cavity",
        "The Trop-2 signalling network in cancer growth",
        "TROP2 expression as prognostic marker for gastric carcinoma",
        "TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas",
        "Clinical significance of TROP2 expression in colorectal cancer",
        "Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules",
        "Retrieved endogenous biotin: A novel marker and a potential pitfall in diagnostic immunohistochemistry",
        "Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: Systematic review and diagnostic meta-analysis",
        "Malignant transformation of thyroid follicular cells by galectin-3",
        "The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer",
        "Clinicopathological relevance of BRAF mutations in human cancer",
        "Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)",
        "Enhanced delivery of SN-38 to human tumor xenografts with an anti-Trop-2-SN-38 antibody conjugate (sacituzumab govitecan)",
        "I hyroid intrafollicular neoplasia (TIN) as a precursor of papillary microcarcinoma",
        "Integrated Genomic Characterization of Papillary Thyroid Carcinoma",
        "Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis",
        "Significance of EpCAM and TROP2 expression in non-small cell lung cancer"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Ratchadapiseksompoch Endowment Fund",
        "Chulalongkorn University",
        "Chulalongkorn University"
    ]
}